Ikenna Ojukwu advises public and private companies on a broad range of corporate matters, including domestic and cross-border mergers and acquisitions, corporate governance and compliance matters, and other strategic transactions. He also advises private equity funds and other financial institutions on high-stakes acquisition financings, various credit facilities, and cross-border financings.
His representative experience includes advising BioMarin in connection with its $4.8 billion acquisition of Amicus Therapeutics. He has worked with clients across a range of industries, including technology, fintech, life sciences, consumer products, and retail.
Ikenna also maintains an active pro bono practice, including representing survivors of human trafficking seeking post-conviction relief and advising pro se litigants.
Expérience
- University of California, Irvine (J.D. 2025; Top 16, UCI Law Moot Court Competition); University of California, Santa Barbara (B.S. in Biopsychology and B.A. in Communication and Media Studies 2021)
- California
- Extern, U.S. Equal Employment Opportunity Commission (Spring 2024)
- Igbo (Nigeria)